Trial Profile
Comparison of stepwise treatment of asthmatic children with salmeterol/fluticasone propionate combination product (Seretide) and/or fluticasone propionate (Flixotide) based on PD20 methacholine and symptoms or based on symptoms only (children asthma therapy optimal)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jun 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms CATO
- Sponsors GlaxoSmithKline; GSK
- 09 Apr 2007 New trial record.